Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Severe COVID-19 often leads to hair loss in India.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Lower vitamin D levels are linked to more severe alopecia areata.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Lower vitamin D levels are linked to more severe hair loss in men.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

miR-155-5p can help diagnose and track alopecia areata severity.

The ProScope HR is an effective, user-friendly, and affordable tool for diagnosing hair loss.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Scoring systems help doctors assess and treat skin diseases effectively.